These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis. Krüger-Krasagakis S; Galanopoulos VK; Giannikaki L; Stefanidou M; Tosca AD Br J Dermatol; 2006 Mar; 154(3):460-6. PubMed ID: 16445776 [TBL] [Abstract][Full Text] [Related]
9. Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor. Suttle MM; Nilsson G; Snellman E; Harvima IT Clin Exp Immunol; 2012 Sep; 169(3):311-9. PubMed ID: 22861371 [TBL] [Abstract][Full Text] [Related]
10. Etanercept does not have an apoptosis-inducing effect on psoriatic keratinocytes. Tatlican S; Arikok A; Gulbahar O; Eren C; Cevirgen B; Eskioglu F J Dermatolog Treat; 2010 Sep; 21(5):306-10. PubMed ID: 19878038 [TBL] [Abstract][Full Text] [Related]
11. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. Fischer M; Harvima IT; Carvalho RF; Möller C; Naukkarinen A; Enblad G; Nilsson G J Clin Invest; 2006 Oct; 116(10):2748-56. PubMed ID: 16964309 [TBL] [Abstract][Full Text] [Related]
12. Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin. Keijsers RR; van der Velden HM; van Erp PE; de Boer-van Huizen RT; Joosten I; Koenen HJ; van de Kerkhof PC Br J Dermatol; 2013 Jun; 168(6):1294-302. PubMed ID: 23330679 [TBL] [Abstract][Full Text] [Related]
13. Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin. Smit JV; de Jong EM; van Hooijdonk CA; Otero ME; Boezeman JB; van de Kerkhof PC J Am Acad Dermatol; 2004 Aug; 51(2):257-64. PubMed ID: 15280845 [TBL] [Abstract][Full Text] [Related]
15. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. Mashiko S; Bouguermouh S; Rubio M; Baba N; Bissonnette R; Sarfati M J Allergy Clin Immunol; 2015 Aug; 136(2):351-9.e1. PubMed ID: 25792465 [TBL] [Abstract][Full Text] [Related]
16. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine. Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379 [TBL] [Abstract][Full Text] [Related]
17. Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin. Johansen C; Flindt E; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L J Invest Dermatol; 2005 Jun; 124(6):1284-92. PubMed ID: 15955105 [TBL] [Abstract][Full Text] [Related]
18. The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis. Adişen E; Gülekon A; Erdem O; Dursun A; Gürer MA J Eur Acad Dermatol Venereol; 2006 May; 20(5):527-33. PubMed ID: 16684279 [TBL] [Abstract][Full Text] [Related]
19. Cetirizine reduces the number of tryptase-positive mast cells in psoriatic patients: a double-blind controlled study. Pestelli E; Caproni M; Giomi B; Volpi W; Spallanzani A; Cardinali C; Floriani I; Fabbri P Int J Tissue React; 2001; 23(3):97-103. PubMed ID: 11517856 [TBL] [Abstract][Full Text] [Related]
20. Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions. Kokolakis G; Giannikaki E; Stathopoulos E; Avramidis G; Tosca AD; Krüger-Krasagakis S Br J Dermatol; 2012 Mar; 166(3):491-7. PubMed ID: 21985184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]